Bristol-Myers Squibb Company Income Statement Analysis

Revenue, earnings, and profit margins in billions USD

Scroll to see more
Bristol-Myers Squibb Company income statement - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue48.1948.3045.0146.1646.3942.5226.1522.56
Cost of Revenue13.1920.8710.6910.149.9411.778.086.47
Gross Profit35.0027.4334.3136.0236.4530.7518.0716.09
Operating Expenses
Research & Development9.499.789.309.5110.2011.146.156.33
Selling, General & Administrative7.157.997.777.817.667.664.874.55
Operating Expenses19.9617.7726.1226.9227.8718.8015.4910.98
Operating Income15.049.668.2029.118.5733.0721.785.11
Other Income/Expense
Interest Income0.590.000.450.170.040.120.000.00
Interest Expense-1.891.951.171.23-1.30-1.380.000.18
Other Income/Expense1.86-18.041.41-0.161.71-2.310.941.04
Income
Income Before Tax9.33-8.388.447.718.10-6.874.985.97
Income Tax Expense2.270.550.401.371.082.121.521.02
Net Income7.05-8.958.036.336.99-9.023.444.92
Net Income - Continuous Operations0.00-8.958.046.357.010.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.000.00
EBITDA19.113.1719.3719.2219.334.938.656.79
EBIT15.049.719.618.958.57-5.455.226.15
Depreciation & Amortization4.079.609.050.5910.760.590.550.10
Earnings Per Share
Basic EPS3.00-4.004.003.003.00-4.002.003.00
Diluted EPS3.00-4.004.003.003.00-4.002.003.00
Basic Shares Outstanding2.032.032.072.132.222.261.711.63
Diluted Shares Outstanding2.042.032.082.152.252.261.711.64